September 9, 2021
Announcing Conscio Pharmaceuticals
Quinta are enormously proud to announce the opening of their new, USA-based affiliate company, Conscio Pharmaceuticals Inc.
September 9, 2021
Quinta are enormously proud to announce the opening of their new, USA-based affiliate company, Conscio Pharmaceuticals Inc.
September 2, 2021
Administration of medication requires a thorough understanding of how and when it moves through the body, possible side effects or reactions, and the correct way to deliver it.
August 26, 2021
It’s not always easy to manage the array of dietary requirements, veterinary needs, and overall health of your furry, fluffy, or indeed scaly companions.
August 18, 2021
As the prevalence of mRNA vaccines starts to take a solid foothold and their development rapidly into other medicinal areas hits new heights, finding the right pharma services company has become ever more a challenge.
August 12, 2021
Whatever size your firm, it's essential to deliver on client expectations.
August 5, 2021
Before taking the plunge and carrying out a full-scale bioequivalence trial, it is typically desirable to dip your toe in the water, and often makes a lot of business sense, to first conduct a pilot trial.
July 28, 2021
The information that has been unlocked is vast, and indeed is being hailed as one of the most important datasets since the mapping of the Human Genome.
July 21, 2021
Soon to become the single entry point for submitting clinical trial information in the EU, we present the Clinical Trial Information System (CTIS).
July 15, 2021
Are small and medium enterprises (SME’s) really a major driver of innovation in the pharmaceutical industry?
July 7, 2021
It's clear to see the continued dominance of the Nitrosamines topic, and the impact the stringent rules and regulations are having on the industry.
July 1, 2021
Nothing short of complex, and requiring highly intricate detail to conduct, the assessment of bioequivalence is a critical component in getting any new drugs to market.
June 28, 2021
This week sees the pharma industry get together virtually once more as the CPhI Conferences Nitrosamine Impurities Forum 2021 gets underway.
June 23, 2021
Before a new medicine or biologic can be marketed, its sponsor must show, through adequate and well-controlled clinical experiments, that it is effective.
June 17, 2021
As everyone in the pharma world knows, stability testing is one of the most crucial steps in the development of new drug products.
June 10, 2021
Across the pharma world, the alignment to guidelines and rules set out by the regulatory authorities must be not only met but exceeded in order to deliver success.
June 3, 2021
This week we celebrated our teams, getting back to normal, and the arrival of summer.
May 27, 2021
World-leading companies such as QUINTA-ANALYTICA are embracing new technologies critical to revolutionizing research, attracting patients for trials, and reducing the speed of delivering results.
May 24, 2021
Quinta has received EU funding toward the construction of it's new research and development laboratory in Brno, Czech Republic.
May 19, 2021
Crossover trials are clinical experiments in which participants are randomly assigned to a sequence of treatments wherein each participant serves as their own control in estimating effects.
May 13, 2021
As an employer of hundreds of professionals, QUINTA-ANALYTICA takes staff engagement, motivation, and culture incredibly seriously.
May 6, 2021
The team are pleased to announce delivery of our latest innovative piece of technology, allowing us to offer even greater selectivity and sensitivity to our clients and partners.
April 28, 2021
EcoVadis is the world’s most trusted provider of business sustainability ratings, and their sustainability scorecard ranked Quinta amongst the top companies assessed.
April 22, 2021
Quinta-Analytica's facilities in our HQ in Prague and also at our newest lab in Brno passes the latest GMP inspection by the Czech State Institute for Drug Control, SUKL.
April 15, 2021
If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further.
April 8, 2021
A generic drug contains the same chemical substance as a drug that was originally branded and protected by patents (now expired).
April 1, 2021
Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.
March 25, 2021
Offering a full range of clinical pharmacology solutions, bioavailability, interaction, bioequivalence, and much more, our purpose-built clinic allows for a huge range of trials.
March 17, 2021
The repositioning of existing drugs could be one of the keys to quickly seek effective drugs to reduce mortality and morbidity.
March 10, 2021
An essential part of QUINTA-ANALYTICA’s service portfolio, its BioPharma team offers comprehensive support.
March 4, 2021
The world moves forward, and so do we. Introducing our new look website.
February 25, 2021
Quality Control project management is an independent and essential function within the analytical operations department.
February 18, 2021
Offering extensive experience in the field of bioequivalence studies from project design and documentation, through clinical and bioanalytical work complete with full statistical clinical reports.
February 11, 2021
Working both with methods provided by customers and those developed by our Analytical R&D teams, we offer a very flexible approach to meet your needs and be your true pharma partner.
February 4, 2021
Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.
January 27, 2021
Viscosity is a principal parameter when any flow measurements of fluids, such as liquids, semi-solids, gases, and even solids are made.
January 19, 2021
The world is fast running out of effective antibiotics as bacteria evolve to develop resistance to our taken-for-granted treatments.
January 12, 2021
This presentation by the European Medicines Agency on Covid-19 drug testing monitoring.
January 7, 2021
Our API Solutions truly remove complexity and bring true value to your developmental process.
December 28, 2020
Offering a comprehensive end-to-end service in collaboration with a strategic partner, QUINTA-ANALYTICA can offer everything from preclinical development to toxicological (TK) studies.
December 21, 2020
Wishing our clients, colleagues, and friends all the very best for a healthy, prosperous, and exciting 2021!
December 17, 2020
Offering incredible accuracy and lightning-fast results, there is no better way to verify the identity of precursor materials used in the preparation of your drugdevelopment.
December 9, 2020
We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek!
December 2, 2020
We are excited and very proud to welcome Dr. Ondrej Palan to the Quinta team!
November 26, 2020
Stay safe and celebrate this holiday season in good health!
November 19, 2020
Regardless of the study phase, magnitude of the trial, dosage forms, or trial design, getting your packaging and labeling right is critical.
November 12, 2020
Electrochemiluminescence is a highly successful detection system that achieves clinical quality data in a variety of sample types.
November 5, 2020
The free-of-charge event strives to get the widest audience possible from health and medicines R&D together.
October 29, 2020
With Brexit looming and the UK PM Boris Johnson saying last week that we must prepare for 'no deal', the pharma industry is on tenterhooks.
October 23, 2020
The pharmaceutical industry is seeing a shift toward personalized medicines, and it’s evolving to deliver this via some exciting new tools.
October 16, 2020
Starting October 19th developers of human or veterinary medicines are instructed to use the EMA's new platform to request scientific advice.
October 9, 2020
It should be a given fact for an industry so important to the world as pharmaceutical, but it’s still reassuring to see it announced publicly.
September 29, 2020
With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!
September 22, 2020
Here’s what you need to know from the FDA’s updated guidance for clinical trials during the pandemic.
September 17, 2020
The Royal Society of Chemistry has announced that its full collection of research journals are now available.
September 9, 2020
If your drug has been suspended, get in touch to see how we can help.
September 2, 2020
Working with key research projects Quinta are proud to be doing their part in the collective effort to rid the world of the most impactful issue ever seen.
August 27, 2020
Quinta have been granted approval into the French Tax Credit system.
August 17, 2020
We’ll be attending the “Nitrosamines Impurities Forum (Americas)” next week. Will you join us?
August 11, 2020
The European Medicines Agency just announced yet another extension for the testing of Nitrosamines contamination.
August 3, 2020
We have been quietly working behind the scenes on our new state of the art, ultra-modern lab capable of handling even the most highly potent drugs.
July 23, 2020
Members of the public, professionals, academia and researchers in the pharmaceutical industry are invited to contribute to the EU's pharma strategy.
July 15, 2020
The FDA announced draft guidance this week to help facilitate the development of new animal drug products.
July 7, 2020
Following the cancellation of 2020 events worldwide, CPhI organizers have decided to transform the world’s largest pharma exhibition into a digital event.
July 1, 2020
Last week saw the publication of the European Medicines Agency report detailing what lessons can be learnt from the cases of unexpected N-nitrosamine impurities in sartans, which came to light mid-2018.
June 25, 2020
What happens when the US FDA, European Commission and European Medicines Agency all get together?
June 16, 2020
This week saw the successful completion of the first bioequivalence study in the Czech Republic, and likely the first in Europe, since the Covid-19 outbreak began.
June 10, 2020
Should drug manufacturing move back to Europe from Asia?
June 4, 2020
To ensure patient safety its paramount to include the testing of starting materials in your overall production plan.
May 28, 2020
QUINTA-ANALYTICA uses plasma protein equilibrium dialysis and LC-MS / MS to determine this critical binding for its partners.
May 22, 2020
When you need ultimate precision and flexibility, you need some rather special equipment!
May 13, 2020
The European Medicines Agency has recommended the suspension of all Ranitidine medicines in the EU.
May 4, 2020
Are you conducting or planning a clinical trial focusing on the treatment of COVID-19? We are well placed to support you.
April 28, 2020
The workhorse of laboratories across the world, the pipette, has a deep and wonderful history.
April 23, 2020
Thanks to the partnership of Chartwell Actives LLC and QUINTA-ANALYTICA we help ensure that your development process is nitrosamine free.
April 20, 2020
Greene Street Pharmaceuticals appoint QUINTA-ANALYTICA as exclusive API sourcing supplier.
April 14, 2020
The deadline has been extended to October 1st, but the countdown still continues.
April 3, 2020
CPhI has worked quickly to secure new dates for a handful of its 2020 events, and so far has confirmed new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America.
March 30, 2020
Times of crisis overwhelmingly bring out the good in society, however they also see the fakes and counterfitters crawl out from their shadowy world.
March 24, 2020
Based on isotopically labeled standards, our customizable in-house detection methods are immediately available.
March 16, 2020
Updated: Apr 1st | Pharma-related events which have been impacted by the spread of coronavisus disease COVID-19. Take a look at our event overview to see if it's affected your plans.
February 17, 2020
Quinta-Analytica will be presenting its robust and versatile LC/MS/MS method during upcoming compliance meeting Nitrosamine Impurities organized by European Compliance Academy on February 18th, 2020 in Frankfurt.
February 11, 2020
A methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia.
February 4, 2020
QUINTA-ANALYTICA are proud to be one of the only companies in the world able to offer a significant LLOQ method of Tiotropium Bromide testing to our clients.
January 24, 2020
Last year the FDA’s Center for Drug Evaluation and Research issued dozens warning letters for manufacturing issues to pharma companies outside the U.S. One country in particular received the highest amount.
January 10, 2020
Spray-dried dispersions have some unique characteristics, and there are some important formulation and processing parameters to be considered when creating and incorporating ASDs into common dosage forms.
December 16, 2019
We're thrilled with the new USP Apparatus 4 (Flow-through Cell Apparatus) in our dissolution studies!
December 10, 2019
Our CEO was a guest speaker at the First International Forum on Innovation and Research of Drugs for Cancer event in Tianjin, China
November 14, 2019
How did a small Czech Republic based pharma company hit the International stage?
October 10, 2019
CPhI Worldwide is the world's largest pharmaceutical exhibition, representing each stage of the supply chain from APIs, machinery and packaging to outsourcing and biopharmaceuticals.
September 24, 2019
QUINTA-ANALYTICA's own Dr. Miroslav Ryska was just awarded the Ioannes Marcus Mardi Medal for Outstanding Achievement.
September 3, 2019
We love Sweden and we can't wait to be in beautiful Malmö attending NLSDays 2019 next week! Be sure to come and say hello if you'll be in town too.
August 29, 2019
The pharmaceutical industry is dependent on research and development as much now as ever. Here we look at some of the of key areas that are currently catching the attention of our industry.
July 24, 2019
Quinta Analytica once again attended CPhI in Shanghai, China a few weeks ago, and as usual it was an exciting and productive event. This year saw huge attendance numbers, and about 3,200 exhibitors from all around the world.
July 18, 2019
On the anniversary of the 2018 FDA Bioanalytical Method Validation Guidance publication, we assess the implications it's brought to the industry.
June 5, 2019
Whether you are looking for sourcing new business or getting the latest market insight, this is your pharmaceutical platform in Asia.
May 28, 2019
BIO International Convention celebrates the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough.
April 3, 2019
Quinta-Analytica will attend CPhI North America 2019 in Chicago as part of the pharmaceutical industry’s most established community. We hope to see you there!
March 11, 2019
Following a successful inspection in January 2019 by the State Institute for Drug Control in Prague, Quinta-Analytica is one of the first companies whose inspection report has been requested by the US FDA from the State Institute for Drug Control.
March 4, 2019
We'll be attending the Bio-Europe Spring 2019 conference in the beautiful city of Vienna, Austria. Meet us there!